IDentification of Factors Predictive of Tofacitinib's Survival in Patient With Rheumatoid Arthritis

Clinical trial NCT03981900 · COMPLETED

Trial details

NCT number: NCT03981900
Sponsor: Pfizer
Status: COMPLETED
Study type: OBSERVATIONAL

Arthritis, Rheumatoid

Start date: 2019-01-04
Primary completion: 2023-02-06
Enrollment: 314

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.